INTRODUCTION: THE EXPOSOME -A NEW SCIENCE
The 'exposome' is defined as the totality of environmental exposure from conception to death [1, 2] . Although characterizing the exposome is a monumental goal, many of the tools to measure environment on an 'omic' scale already exist, and recent advances in analytical chemistry, geospatial statistics, and the same scientific and cultural developments that made smart phones ubiquitous now make the goal of estimating the exposome possible. In the next 10 years, more and more research will be conducted in 'exposomics'. To build toward this larger goal, environmental health researchers must integrate a vast array of tools from multiple, seemingly disparate, scientific disciplines to successfully measure the exposome. In many ways, environmental health is at a similar development stage as genomics was 15 years ago. We can therefore learn several lessons from genomics, which already transitioned from a hypothesis driven science to a hypothesis generating 'omic' science. The growth of genomics was propelled by embracing the best of multiple fields and building teams, and did not emanate from laboratories that were focused on a single aspect of genomics: a combination of biologists, physicians, bioinformaticists, computer scientists, statisticians, and an appreciation of 'big data' drove the growth of genomics. By merging multiple fields, geneticists forced a need for the development of new technology, the enrollment of large study populations, and the creation of bioinformatic tools that could manage larger and larger amounts of data efficiently. This led to consortiums and further collaboration among epidemiologists, molecular biologists, bioinformaticians, statisticians, and clinicians. The key to the rapid development of exposomics will be to follow this blueprint of success, and the NIH Child Health Exposure Analysis Resource (CHEAR) program provides a strong foundation. CHEAR will provide researchers with the tools to measure the exposome. Similar to genomics, the initial measures will be targeted (just as single nucleotide polymorphisms in microarrays were the mainstay assay 5-10 years ago) but, as exposomic technology improves, environment will be measured on larger and larger scales.
ENVIRONMENT IS KEY TO UNDERSTANDING THE GENOME
In the last two decades, genomics profoundly changed the fundamental approach to science by moving away from hypothesis-driven research to agnostic, hypothesis-generating research followed by hypothesis testing replication. Although genomics has rapidly advanced our understanding of the underlying biology of disease, actual diseasecausing genetic variants are rare and account for no more than $20% of the variance that explains the cause of complex diseases. Even in diseases such as autism, in which the genetic contribution was once predicted to be 80-100% of the heritability, the concept that measuring genetics alone could explain the root cause of the disease has fallen out of favor. Much debate has occurred over the source of this 'missing heritability'. The underlying assumption of heritability estimates is that genetics and environment act independently to cause disease and, by doing so, we typically overestimate the genetic contributions. In reality, genes and environment cannot work independently; they must interact, as even mutated genes require substrates to generate gene products. Research in the last 20 years has focused on unraveling the genetic component of disease risk, whereas the effect of environmental stimuli received limited attention. In large part, the lack of focus on environmental causes was driven by the absence of tools to measure the environment on an 'omic' scale. Until recently, although millions of single nucleotide polymorphisms could be measured in a population, interactions with environmental risk factors were limited to a handful of measurements. This discordance tended to minimize the importance of environment. Further, these environmental risks were chosen not because they were known to interact with given genetic variants but primarily because they were easiest to measure. Environmental exposure assessment technology has exploded in the last few years and continues to develop. In recent years, many have concluded that gene Â environment interactions likely explain the largest portion of the missing heritability [3, 4] . The time is now ripe to leverage these gains and conduct geneenvironment interaction investigations on a scale that can discover and replicate findings via both genomic and exposomic approaches.
LINKING EXPOSOMICS WITH GENOMICS
Although an emerging consensus suggests that prevalent complex diseases in humans develop as a result of multiple biologically unique geneenvironment and environment by environment interaction (Fig. 1) , this conceptual framework remains limited. In fact, the development of disease in humans is far more complex and is not even a three-dimensional issue (i.e., involving multiple interactions) but a four-dimensional issue (i.e., changes in interaction-related risk over time). Environmental exposures affect those who are vulnerable temporally (age at time of exposure) and by unique circumstance (comorbid disease, nutritional status, economic status, culture, genetics). Even this paradigm fails to address the complex interaction of endogenous and exogenous chemicals that ultimately interact to cause disease. Human genetics provided an unparalleled insight to understanding how genes and genetic variants interact with environmental exposures to either preserve health or cause disease. These advances have led to the concept of systems biology research and the study of genetic variants as networks instead of individual predictors. However, as currently practiced, Systems Biology is an incomplete science. Without accounting for the temporal, spatial, and other unique components of an individual's microenvironment, our understanding of genetics and gene networks remains incomplete. Even the downstream products of genes (transcriptomics, proteomics, metabolomics, and so on) are only partial
KEY POINTS
The exposome is a new science that assesses the totality of human exposure from conception to death.
Measuring environment rigorously will improve our understanding of genomics and developmental biology.
The next decade will see enormous advances in our ability to measure human environment across all life stages.
Windows of susceptibility are the key to understanding how genes and environment interact.
Multidisciplinary teams are needed to avoid pitfalls that arise from focus on technology rather than biology and rigorous study design and statistics.
pieces of a much larger puzzle. Understanding the complex relationships among our genetic code, our metabolic machinery, and our temporally changing environment in populations and within affected individuals is precisely the opportunity and challenge that scientists involved in both environmental health and genomics face.
THE UNIQUENESS OF CHILDREN'S HEALTH RESEARCH: OPPORTUNITIES AND PITFALLS
Over the last two decades, a growing appreciation for the role of fetal/childhood environments on child and adult health has come to the forefront. The field of 'developmental origins of health and disease (DOHaD)' has even developed to the point where it now hosts an international society with an annual conference (https://dohadsoc.org/). Concurrent to these developments has been the rise of 'omic' science (genomics, epigenomics, proteomics, and metabolomics among others). These technology-driven fields have led to an explosion of measures that can be incorporated into population-based research. Combining the lessons learned from developmental origins with these new technologies will require thoughtful, interdisciplinary approaches that can integrate chemistry, pediatrics, developmental biology, epidemiology, and biostatistics/bioinformatics. For example, factoring in the role of child development in metabolomic assays will be considerably more complex in children than in adults. Adult metabolism can be grouped by years (i.e., the average 35-year old is not particularly different then a 40 years old) whereas in child health, developmental metabolism changes occur in time sets of months or even weeks. Overly simplistic approaches of adjusting for age cannot capture this complexity and will lead to erroneous interpretations of data. In addition, all 'omic' analyses are hypothesis generating and must be replicated, otherwise they will inevitably produce primarily false positive results [5] [6] [7] . Relative to genomics, time varying measures, such as the exposome, metabolome, proteome, and epigenome, must factor age of the child, as the risk of exposure (behaviors, motor development, diet) and response to exposure (metabolism, gene expression variation, cell differentiation, and so on) operate at varying degrees of intensity over childhood life stages. Replication must also be careful to factor in these issues to avoid type 2 error as well as type 1 error. Although the pitfalls are many, so are the potential rewards. The rapid time varying life stages of childhood are an opportunity to build upon the current state of science toward a better understanding of disease cause, prevention, and treatment. With a growing understanding that the childhood environment is often a root cause for adult health and disease, a focused effort to conduct exposomic research during childhood will touch almost every field of biology.
Susceptibility windows and exposure assessment
Fetal life is a state of sequential physiological shifts, driven by cell-specific gene expression changes in which there are dynamic changes in growth rates as well as the establishment of hormonal and metabolic circadian rhythms. This timed cascade of biological events means that the fetus is highly vulnerable to even subtle environmental insults, as cell and tissue differentiation is most active at this life stage, yet defense mechanisms against toxic environmental factors are underdeveloped [8] . These events occur over varying time scales of years, months, weeks, or even days. To produce programmed effects in the absence of overt cellular toxicity, environmental exposures must coincide with these timed developmental processes inducing changes in the developmental trajectory. Some of the earliest reports on DOHaD, came from David Barker's research team, which conducted a series of seminal studies on fetal nutritional environment and subsequent adult cardiometabolic health [9] [10] [11] . Increasingly, the observation that early life nutritional famine was a strong predictor of later life hypertension, obesity and even behavioral disorders such as schizophrenia [12, 13] has become an accepted biological tenet. Research on the fetal chemical and social environment has found many parallel effects to the Barker hypothesis, which have been termed 'windows of susceptibility' or 'critical windows'. To advance the field of developmental origins of disease, exposure assessment must occur at time scales that can assess multiple life stages, sometimes as brief as a few months. Prospective, longitudinally assessed data on environment in multiple life stages is the key to this endeavor. CHEAR can measure multiple toxicants on extant samples to begin the process of systematically searching for critical windows of susceptibility.
Example of environmental programming: oxidative stress
Although many mechanisms may contribute to nutritional or toxicant-elicited disruption of fetal development, a growing body of evidence underscores a central role for oxidative stress (OS) [14, 15] . OS may be a source of toxicity but it is also a signal for normal development [16, 17] . Reactive oxygen species are needed to induce the timed transcription of genes critical to cell differentiation and proliferation [16] . During pregnancy, increased placentation and oxygenated blood flow coincide with rapid growth and increased oxygen needs, creating a switch in the fetal redox state from reduced to oxidized. This switch is critical to timed gene expression changes and drives cell and tissue differentiation. The placenta regulates the delicate balance between normal and excess reactive oxygen species generation, preventing toxicity and promoting cell differentiation. Hypoxemia and poor nutrition cause oxidative stress [18] [19] [20] and can be driven by maternal health/environment, nutrient/waste exchange, and placental vascular reactivity. Chemical oxidants can be directly fetal toxic if transferred across the placenta, but may also induce cytokines and other inflammatory mediators that constrict placental blood flow, mimicking famine-like effects [21, 22] . In either case, oxidants alter normal gene expression signals, producing a stressed fetal environment. The key concept is that the fetus may react to a hostile in-utero environment by programming gene expression in preparation for a similarly hostile ex-utero life. However, if ex-utero resources are plentiful, these programmed gene expression changes can become detrimental.
Mechanisms of oxidative stress and fetal programming
How might oxidative stress cause programming? Oxidative stress impacts multiple heritable cellular processes including DNA methylation/imprinting, mitochondrial DNA (mtDNA) function, and telomere biology, all of which influence programming [23] [24] [25] [26] [27] . The placenta, which is the gateway to the fetus, is highly sensitive to these pro-oxidant stressors. All have the potential to alter biochemical, molecular, epigenetic, and gene expression processes (Fig. 2) . Thus, the placenta provides a readily available source of integrated molecular information on the cumulative past oxidative stress that occurred over pregnancy. Moreover, which pathways are disrupted, and/or which disorder originates, may depend as much on timing as on differences in exposures [26, 28] . Key challenges for future research include whether we can identify biomarkers at the maternal-fetal interface that reflect an integrated measure of mixed oxidant exposures over pregnancy and how to better estimate the influence of exposure timing.
Untargeted chemical profiling
The vast majority of children's environmental health studies have focused on one or, at most, a few candidate chemicals or metabolites which may cause disease or disorders in children. Although there are strengths to such an approach, including biologic plausibility and clear a-priori hypotheses, there are also limitations to selecting only a few environmental exposures in a single study. Human population studies take years to conduct and are expensive, and this pace of research is very limiting with regards to informing healthcare providers and public policy makers. In addition, given the multifaceted nature of biologic interactions, it is difficult to conceive that one environmental exposure can ever primarily account for the rise of complex diseases such as asthma, autism, obesity, and so on. Finally, there are certainly chemicals/metabolites important to disease pathogenesis or child development that are not yet known, and keeping in mind that more than 80 000 chemicals are registered with the Environmental Protection Agency for commercial use in the United States [29] , a candidate exposure approach may never be able to identify the chemical and nonchemical mixtures driving disease processes. The selection of environmental exposures in candidate studies is always open to bias. That is, we tend to study what we already believe or suspect is toxic. If we are to keep pace, we must rethink our approach to environmental health research [2, 30] . Similar to the field of genetics that capitalized on the genome wide scan to advance new genetic 'discoveries', environmental health must begin to utilize untargeted scans allowing for screening of the exposome to 'discover' novel environmental risk factors and their effects [1, 31] . Advances in analytical chemistry methods now allow assessment of exposure to hundreds to thousands of untargeted classes of chemicals by performing global screening of small molecules using methods such as liquid chromatography coupled with quadrupole time-of-flight mass spectrometry metabolomics. Our team has even applied this technology to novel matrices such as teeth that can reconstruct exposures from fetal life and infancy [32] . We found more than 12 000 unique chemical signatures in trimester-specific dentine layers, high inter-and intra-child variability in chemical profiles, and 'known unknown' and 'suspected unknown' compounds. Because we used teeth, reconstruction of exposures was carried out 7-10 years after prenatal and early childhood exposure. A similar approach could be applied to ongoing studies, even those that did not collect prenatal biospecimens enabling exposomic research on prenatal exposure even with prospective sample collection in pregnancy. FIGURE 3 . Associations between weekly prenatal PM 2.5 and mtDNA content in cord blood adjusted for sex, maternal age at delivery, year of birth, maternal education, prenatal exposure to environmental tobacco smoke, and batch. The y-axis represents the change in mtDNA content associated with a 10 mg/m 3 increase in PM 2.5 ; the x-axis is gestational age in weeks. Solid lines show the predicted change in mtDNA content. Gray areas indicate 95% confidence intervals (CIs). A sensitive window is identified for the weeks where the estimated pointwise 95% CI (shaded area) does not include zero (i.e. the length of time the regression is statistically significant). Reproduced with permission [35] .
Environment, susceptibility windows, development, and child health Wright
Statistical methods must integrate with exposure and biology
Given its complexity, exposome research will require a team-based approach to assess the relationship between environment and health, integrating exposure science, with pediatrics, developmental biology, and statistics. To illustrate, our team recently developed a new approach to identifying developmental windows of susceptibility using air pollution exposure data collected daily. The concept of 'windows of susceptibility' implies that exposure timing determines subsequent health effects [28, 33, 34] . Because of the rapidity of development, windows of susceptibility can be missed if exposure measures are made outside the appropriate window, even if the correct chemical is assessed; however, the time boundaries of windows are rarely known and researchers effectively are left to guess when the windows occur. If we could measure exposure repeatedly over short, frequent time periods rather than collecting serial exposure measures months or years apart, then we could use data-driven methods to objectively identify windows of susceptibility. To facilitate such an approach, we have proposed novel methods that provide highly temporally resolved exposure data thereby coupling our novel exposure methods with data-driven statistics to determine the windows of susceptibility in which air pollution (PM 2.5 , particulate matter <2.5 mm in diameter) exposure predict health outcomes. Figure 3 is a previously published result illustrating this concept using prenatal PM 2.5 measured weekly across pregnancy to estimate mitochondrial DNA copy number, a biomarker of cumulative oxidative stress [35 & ]. The Distributed Lag Regression Model reveals that the critical window for this mixture is found in the late third trimester. These data-driven methods to identify critical windows may well be a 'rosetta stone' in biological science [35 & ,36 & ], as critical susceptibility windows are in nearly all cases, ill defined.
CONCLUSION
These are exciting times for Environmental Health and Exposure Science. The field has made tremendous strides toward developing an exposomics approach to its research in recent years [37] [38] [39] . CHEAR represents the type of infrastructure achievements that create the foundation for the development of new methods and new consortia that can address the big picture questions of how environment impacts health and development. Future research will no doubt generate new methods for exposure assessment, data harmonization, and statistical approaches but, with respect to children's health, will need to factor in the time varying biological processes that define childhood. The CHEAR program is well positioned to deliver the research tools that will bring the nascent field of exposomics to the forefront of medical science.
